Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RxSight, Inc. | Director | Common Stock | 1.39M | $66.5M | $48.00 | Aug 3, 2021 | Indirect |
EXAGEN INC. | Director | Stock Option(right to buy) | 9K | Jun 17, 2021 | Direct | ||
RxSight, Inc. | Director | Series G Preferred Stock | 0 | Aug 3, 2021 | Indirect | ||
RxSight, Inc. | Director | Series H Preferred Stock | 0 | Aug 3, 2021 | Indirect | ||
RxSight, Inc. | Director | Warrant (right to buy) | 0 | Aug 3, 2021 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RXST | RxSight, Inc. | Aug 3, 2021 | 7 | $0 | 4 | Aug 5, 2021 | Director |
RXST | RxSight, Inc. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
XGN | EXAGEN INC. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |